Variant Ii Hemoglobin A1C Program
Assay, Glycosylated Hemoglobin. 510(k) K984268, from Bio-Rad (Hercules, CA). Product code LCP, class 2.
As of Nov 20, 2026, K984268 is an FDA 510(k) held by Bio-Rad, substantially equivalent on Dec 17, 1998 after 17 days, with 2 recalls tied to it in FDA's recall database.
- Review time: 17 days
- Recalls: 2
- Cited as a predicate by: 6 devices
The VARIANT™ II Hemoglobin A_{1c Program is intended for the determination of hemoglobin A_{1c in human whole blood using ion-exchange high performance liquid chromatography (HPLC). The VARIANT™ II Hemoglobin A_{1c Program is intended for use only with the Bio-Rad VARIANT™ II Hemoglobin Testing System. For in vitro diagnostic use only.
- Variant(Tm) Hemoglobin A 1C ProgramK926469 · Bio-Rad · Mar 29, 1993
- Variant Ii Hemoglobin A1C Program With Models 270-2101NUK070452 · Bio-Rad Laboratories, Inc. · May 7, 2007
- Modification To Variant Ii: Hemoglobin A1C Program, Beta-Thalassemia Short Program and Total Ghb ProgramK063643 · Bio-Rad Laboratories Inc., Clinical Systems Divisi · Dec 27, 2006
- Bio-Rad D-10 Dual ProgramK041444 · Bio-Rad Laboratories, Inc. · Jun 9, 2004
- Variant Ii Hemoglobin A1CK040872 · Bio-Rad Laboratories, Inc. · Apr 15, 2004
- D-10 Hemoglobin A1CK031043 · Bio-Rad Laboratories, Inc. · Aug 27, 2003
- Infinity Hba Kit, Models 537-A, 537-BK012410 · Sigma Diagnostics, Inc. · Oct 26, 2001
| Started | Recall | Status |
|---|---|---|
| Jan 22, 2009 | Z-1902-2010, Z-1901-2010Sample test results for the first run appears to be correct but all subsequent results during that run were assigned incorrect barcode and tube position. | Terminated |
- Q-Pad Test SystemK231465 · Qurasense · Dec 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 30, 1998
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files